A utility approach to individualized optimal dose selection using biomarkers

DOI10.1002/BIMJ.201900030zbMATH Open1436.62590OpenAlexW2987024930WikidataQ91136516 ScholiaQ91136516MaRDI QIDQ3299111FDOQ3299111

Authors: Pin Li, Spring Kong, Shruti Jolly, M. Schipper, Jeremy M. G. Taylor 

Publication date: 17 July 2020

Published in: Biometrical Journal (Search for Journal in Brave)

Full work available at URL: https://hdl.handle.net/2027.42/154301

Recommendations

• Utility-Based Optimization of Combination Therapy Using Ordinal Toxicity and Efficacy in Phase I/II Trials
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates
• Bayesian dose-finding in two treatment cycles based on the joint utility of efficacy and toxicity
• Clinical trials for personalized dose finding
• scientific article; zbMATH DE number 2242805

zbMATH Keywords

utilityoptimal treatment regimepersonalized medicineconstrained LASSOefficacy toxicity trade-off

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cited In (4)

• Utility based approach in individualized optimal dose selection using machine learning methods
• Bayesian adaptive design of early-phase clinical trials for precision medicine based on cancer biomarkers
• Title not available (Why is that?)
• Patient‐Specific Dose Finding Based on Bivariate Outcomes and Covariates

This page was built for publication: A utility approach to individualized optimal dose selection using biomarkers

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3299111)